Chemoinformaics analysis of (3á,24s)-,Lup-20(29)-en-3-one
| Molecular Weight | 424.713 | nRot | 1 |
| Heavy Atom Molecular Weight | 376.329 | nRig | 27 |
| Exact Molecular Weight | 424.371 | nRing | 5 |
| Solubility: LogS | -6.746 | nHRing | 0 |
| Solubility: LogP | 7.284 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 82.9081 |
| nHD | 0 | BPOL | 49.0219 |
| QED | 0.387 |
| Synth | 4.643 |
| Natural Product Likeliness | 3.057 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.281 |
| Pgp-sub | 0 |
| HIA | 0.016 |
| CACO-2 | -5.102 |
| MDCK | 0.00000756 |
| BBB | 0.791 |
| PPB | 0.988298 |
| VDSS | 1.805 |
| FU | 0.0248613 |
| CYP1A2-inh | 0.031 |
| CYP1A2-sub | 0.681 |
| CYP2c19-inh | 0.07 |
| CYP2c19-sub | 0.981 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.676 |
| CYP2d6-inh | 0.054 |
| CYP2d6-sub | 0.883 |
| CYP3a4-inh | 0.216 |
| CYP3a4-sub | 0.719 |
| CL | 17.988 |
| T12 | 0.028 |
| hERG | 0.018 |
| Ames | 0.017 |
| ROA | 0.301 |
| SkinSen | 0.038 |
| Carcinogencity | 0.031 |
| EI | 0.117 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.571 |
| Antiviral | No |
| Prediction | 0.660692 |